161 related articles for article (PubMed ID: 7528727)
1. Analysis of HLA-DMB mutants and -DMB genomic structure.
Shaman J; von Scheven E; Morris P; Chang MD; Mellins E
Immunogenetics; 1995; 41(2-3):117-24. PubMed ID: 7528727
[TBL] [Abstract][Full Text] [Related]
2. HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells.
Fling SP; Arp B; Pious D
Nature; 1994 Apr; 368(6471):554-8. PubMed ID: 8139690
[TBL] [Abstract][Full Text] [Related]
3. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules.
Morris P; Shaman J; Attaya M; Amaya M; Goodman S; Bergman C; Monaco JJ; Mellins E
Nature; 1994 Apr; 368(6471):551-4. PubMed ID: 8139689
[TBL] [Abstract][Full Text] [Related]
4. DMA and DMB are the only genes in the class II region of the human MHC needed for class II-associated antigen processing.
Ceman S; Rudersdorf RA; Petersen JM; DeMars R
J Immunol; 1995 Mar; 154(6):2545-56. PubMed ID: 7876531
[TBL] [Abstract][Full Text] [Related]
5. Allelic diversity at the primate MHC-DMB locus: presence of a conserved tyrosine inhibitory motif in the cytoplasmic tail.
Alvarez M; Recio MJ; Martinez-Laso J; Pérez-Blas M; Garcia-de-la-Torre C; Vargas-Alarcón G; Alegre R; Gomez-Casado E; Arnaiz-Villena A
Tissue Antigens; 1998 Feb; 51(2):174-82. PubMed ID: 9510373
[TBL] [Abstract][Full Text] [Related]
6. The DMB promoter: delineation, in vivo footprint, trans-activation, and trans-dominant suppression.
Ting JP; Wright KL; Chin KC; Brickey WJ; Li G
J Immunol; 1997 Dec; 159(11):5457-62. PubMed ID: 9548486
[TBL] [Abstract][Full Text] [Related]
7. Isolation and mapping of the rabbit DM genes.
Hermel E; Han M; Hague B; Kindt T; Monaco JJ
Immunogenetics; 1999 Apr; 49(4):295-302. PubMed ID: 10079293
[TBL] [Abstract][Full Text] [Related]
8. Genomic organization of HLA-DMA and HLA-DMB. Comparison of the gene organization of all six class II families in the human major histocompatibility complex.
Radley E; Alderton RP; Kelly A; Trowsdale J; Beck S
J Biol Chem; 1994 Jul; 269(29):18834-8. PubMed ID: 8034636
[TBL] [Abstract][Full Text] [Related]
9. HLA-DMA and HLA-DMB gene expression functions through the conserved S-X-Y region.
Westerheide SD; Louis-Plence P; Ping D; He XF; Boss JM
J Immunol; 1997 May; 158(10):4812-21. PubMed ID: 9144496
[TBL] [Abstract][Full Text] [Related]
10. Exon-intron organization of Xenopus MHC class II beta chain genes.
Kobari F; Sato K; Shum BP; Tochinai S; Katagiri M; Ishibashi T; Du Pasquier L; Flajnik MF; Kasahara M
Immunogenetics; 1995; 42(5):376-85. PubMed ID: 7590971
[TBL] [Abstract][Full Text] [Related]
11. Analysis on allelic variation of the HLA-DMB gene in Japanese by PCR-RFLP as well as direct DNA sequencing and identification of a new DMB allele, DMB*0105.
Naruse TK; Kawata H; Ishihara M; Ando A; Kagiya M; Nose Y; Isshiki G; Inoko H
Tissue Antigens; 1996 Jun; 47(6):530-7. PubMed ID: 8813742
[TBL] [Abstract][Full Text] [Related]
12. Impaired antigen presentation by murine I-Ad class II MHC molecules expressed in normal and HLA-DM-defective human B cell lines.
Weenink S; Averdunk H; Boston T; Boswarva V; Guery JC; Adorini L; Mellins E; McCluskey J; Gautam AM
Int Immunol; 1997 Jun; 9(6):889-96. PubMed ID: 9199972
[TBL] [Abstract][Full Text] [Related]
13. The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes.
Kern I; Steimle V; Siegrist CA; Mach B
Int Immunol; 1995 Aug; 7(8):1295-9. PubMed ID: 7495736
[TBL] [Abstract][Full Text] [Related]
14. Lack of association of DMB polymorphism with insulin-dependent diabetes.
Esposito L; Lampasona V; Bonifacio E; Bosi E; Ferrari M
J Autoimmun; 1997 Aug; 10(4):395-400. PubMed ID: 9237803
[TBL] [Abstract][Full Text] [Related]
15. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
[TBL] [Abstract][Full Text] [Related]
17. Characterization of HLA-DMB polymorphism.
Carrington M; Yeager M; Mann D
Immunogenetics; 1993; 38(6):446-9. PubMed ID: 8406617
[No Abstract] [Full Text] [Related]
18. Targeting signal and subcellular compartments involved in the intracellular trafficking of HLA-DMB.
Copier J; Kleijmeer MJ; Ponnambalam S; Oorschot V; Potter P; Trowsdale J; Kelly A
J Immunol; 1996 Aug; 157(3):1017-27. PubMed ID: 8757605
[TBL] [Abstract][Full Text] [Related]
19. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome).
Steimle V; Otten LA; Zufferey M; Mach B
Cell; 1993 Oct; 75(1):135-46. PubMed ID: 8402893
[TBL] [Abstract][Full Text] [Related]
20. Invariant-cognate peptide exchange restores class II dimer stability in HLA-DM mutants.
Monji T; McCormack AL; Yates JR; Pious D
J Immunol; 1994 Nov; 153(10):4468-77. PubMed ID: 7525705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
